Cyrus Biotechnology
Seattle
About Cyrus Biotechnology
Cyrus Biotechnology builds software tools to accelerate basic research in biotech, pharma, and industrial biotechnology. Cyrus Bench delivers an enterprise version of the Rosetta molecular modeling and design toolkit, with the associated array of bio-molecular computation tools. It was founded in 2014 and headquartered in Seattle, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2024)
- Website: cyrusbio.com
- Phone: (206)258-6561
Industries & Categories
Biotechnology, Nutrition, Software
Social Profiles
Canonical: https://fsome.com/organization/cyrus-biotechnology-77968 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.